We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Latin America’s IVD Sector Exceeds USD 2 Billion, Brazil leads

By LabMedica International staff writers
Posted on 29 Mar 2015
Print article
The Latin American in vitro diagnostics (IVD) sector was estimated at USD 2.4 billion in 2014. Population growth, government insurance, newly insured patients, and updated healthcare facilities have driven growth in the region and will continue to propel demand, according to Kalorama Information (New York, NY, USA).

Kalorama based its finding on market research and interviews with IVD manufacturers and distributors. The analysis, published in Kalorama’s report “The Market for In Vitro Diagnostic Tests In Latin America," focuses on reagents and instruments in the main countries. Brazil, Chile, Columbia, Peru and Argentina are singled out for a deeper level of analysis. Uruguay, Venezuela, Ecuador, and other nations are also considered.

“The maturation of IVD markets in developed countries has IVD companies casting their nets in developing countries where rising incomes and standards of living are anticipated to spark a new health consciousness population with growing demands for quality medical care,” said Bruce Carlson, Kalorama Information publisher, “Latin America is a key target for IVD manufacturers,” expected to give additional opportunities in the near future, at an average annual growth twice the worldwide rate.

Brazil has the number one IVD market in the Latin America. The sector is growing at good pace in Brazil, Chile, and Colombia. Due to their current political and economic situations other nations might lag behind for some time. Kalorama’s report suggests this region’s IVD market is attractive but has large challenges to overcome, about which the report provides guidance.

“One of the challenges is that each country is a world on its own: different regulations on sales, insured populations, reimbursement policies, and a number of logistic issues.” said Mr. Carlson, “That’s why we attempted to provide as much detail as possible by country.” Tailored strategies are needed for each of the countries, which vary in size, healthcare infrastructure, and affordability. Companies preparing to enter this market need to understand regulations, have dedicated bilingual personnel, and optimize post-sales costs through regional training centers.

“Marketing strategies from mature markets might end up failing in these countries,” said Mr. Carlson, “working with distributors that fully understand the region is key.” The report provides information on distributors that lead sales in each country, as well as market share tables for each featured country and for many product categories.

Related Links:

Kalorama Information
Market for In Vitro Diagnostic Tests In Latin America, report


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.